Donald Trump`s popularity lowest of any president in decades: Polls

executive@coastaldigest.com (Agencies)
January 18, 2017

District of Columbia, Jan 18: US President-elect Donald Trump takes office this week with dismal approval and popularity numbers, according to polls out Tuesday, underscoring the deep divisions among Americans as the New York businessman prepares for his inauguration.

trumplift

A CNN/ORC poll showed 40 percent of respondents approved of the way Trump has been handling the transition period heading into Friday`s inauguration, a figure that`s sharply lower than any incoming US president in recent history.

Trump will enter the Oval Office as the least popular incoming president in at least four decades, according to a Washington Post-ABC News poll.

The president-elect immediately slammed the findings, pointing out that a majority of surveys ahead of his November 8 electoral win predicted victory for his Democratic opponent Hillary Clinton.

"The same people who did the phony election polls, and were so wrong, are now doing approval rating polls. They are rigged just like before," he said on Twitter.

The real estate developer who is working in government for the first time has presided over a chaotic and unorthodox transition period since his election.

The recent weeks have featured -- among other things -- a drawn-out search for top cabinet members, questions over conflicts of interest, feuds with the media, unsubstantiated allegations that Russia holds compromising material against Trump, and the president-elect`s Twitter blasts against critics ranging from the CIA chief to the screen legend Meryl Streep.

The CNN poll showed Trump lagging more than 20 points behind the approval ratings of his three most recent predecessors and 44 points below that of President Barack Obama as he prepared to enter the Oval Office in 2009.

Obama had an 84 percent approval rating ahead of his inauguration, Bill Clinton scored 67 percent approval in late December 1992 and 61 percent approved of George W. Bush`s transition in poll figures from January 2001, CNN said.

Forty percent of respondents told the Washington Post-ABC survey they have a favorable impression of the incoming president, compared with 54 percent who said they have an unfavorable impression.

That makes Trump the most unpopular incoming president since at least Jimmy Carter in 1977, the Washington Post said.

Forty-four percent said Trump is qualified to serve as president, as opposed to 52 percent who said he`s not qualified, the Washington Post-ABC poll said.

When asked how much confidence they have that Trump will make the right decisions for the country`s future, 38 percent said they had a great deal or a good amount of confidence. Sixty-one percent said they had just some or no confidence.

The CNN/ORC poll has a margin of error of plus or minus three percentage points. The Washington Post-ABC poll has a margin of error of 3.5 percentage points.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 28,2020

Washington, Mar 28: A US-based lab has unveiled a portable test that can tell if someone has COVID-19 in as little as five minutes, it said in a statement Friday.

Abbot Laboratories said the US Food and Drug Administration (FDA) had given it emergency authorization to begin making the test available to healthcare providers as early as next week.

The test, which is the size of a small toaster and uses molecular technology, also shows negative results within 13 minutes, the company said in a press statement.

"The COVID-19 pandemic will be fought on multiple fronts, and a portable molecular test that offers results in minutes adds to the broad range of diagnostic solutions needed to combat this virus," said Abbot president and chief operating officer Robert Ford.

The test's small size means it can be deployed outside the "traditional four walls of a hospital in outbreak hotspots," Ford said, and Abbott is working with the FDA to send it to virus epicenters.

The test has not been cleared or approved by the FDA, and has only been authorized for emergency use by approved labs and healthcare providers, the company said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
May 9,2020

London, May 9: Air India's first evacuation flight from London will be taking off for Mumbai today.

The screening of passengers is underway.

"Air India's first evacuation flight from London taking off for Mumbai today at 1200. Flight is 100% booked! Shubh Yatra. Please stay in touch. GoI working to send more evacuation flights!" High Commission of India, London said in a tweet.

On Monday, India announced had that it will begin phased repatriation of its citizens stranded abroad from May 7.

The government said that Air India will operate 64 flights in the first week from May 7 to May 13 to bring back around 15,000 Indian nationals.

On day three of the 'Vande Bharat Mission', flights carrying Indians from the Gulf countries, the United Kingdom, Bangladesh and Malaysia will arrive in India.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
March 28,2020

Canadian researchers are developing a DNA vaccine for SARS-CoV-2, the coronavirus that causes COVID-19 and has currently infected nearly 5,00,000 people worldwide and crippled the global economy.

Entos Pharmaceuticals, a health-care biotechnology company headed by a University of Alberta researchers, develop new therapeutic compounds using the company's proprietary drug-delivery platform and has begun manufacturing vaccine candidates against the novel coronavirus.

"Given the urgency of the situation, we can have a lead candidate vaccine within two months. Once we have that it's a race to get it into clinical trials," said John Lewis, CEO of Entos and a Professor at the University of Alberta in Canada.

Lewis said in comparison to a traditional vaccine, DNA-based vaccines hold several advantages.

Nucleic acids are introduced directly into the patient's own cells, causing them to make pieces of the virus--tricking the immune system into mounting a response without the full virus actually being present, the researcher said.

According to the company, the approach is recognised as being easier to move into large-scale manufacturing, offers improved vaccine stability and works without needing an infectious agent.

In the current absence of a vaccine for COVID-19, several companies around the world are mounting efforts to begin similar work.

The first clinical trial using a DNA-based vaccine developed by Moderna Inc.in the US on March 13.

Their approach allows for antibodies to be made in the human trial volunteers against a specific protein on the surface of the coronavirus that lets the virus enter human cells.

The hope is that the antibodies will stop the interaction.

Though this approach is designed to be effective against COVID-19 specifically, Lewis said Entos is taking a different tack.

The company plans to use plasmid DNA to amplify the production of key coronavirus surface and structural proteins with each injection, with an eye to the bigger picture.

"Many of the structural proteins in the virus are pretty well conserved across all the coronaviruses, including SARS and MERS," said Lewis.

"We're hoping that if we express more of the structural proteins that are common to most coronaviruses, we can inhibit the current COVID-19, and also potentially protect against all coronaviruses both past and future," Lewis added.

To move the project forward quickly, the company is seeking financial support from both provincial and federal levels of government.

"We have the opportunity to save a lot of lives, and I think it's really upon us and governments to find solutions for that," Lewis said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.